389 A phase I study evaluating the pharmacokinetics (PK) and pharmacodynamic (PD) activity of the dual PI3K/mTor inhibitor GDC-0980 administered QW
A.J. Wagner; G.C. Jayson; C. Gomez-Roca; Y.K. Zee; J.A. Morgan; Y. Yan; J. Ware; K.E. Mazina; J. Lauchle; J.C. Soria
- 作者A.J. Wagner; G.C. Jayson; C. Gomez-Roca; Y.K. Zee; J.A. Morgan; Y. Yan; J. Ware; K.E. Mazina; J. Lauchle; J.C. Soria
- 卷第8卷
- 期第7期
- 文件大小63.09KB
- 发表时间2010
- DOI10.1016/s1359-6349(10)72096-6
- 页码123-124